When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: The case of cardiorenal syndrome

Critical Care Medicine

Volumn 42, Issue 9, 2014, Pages 2109-2117

  Legrand, Matthieu ^a,b,c   Mebazaa, Alexandre ^a,b,c   Ronco, Claudio ^d   Januzzi, James L ^e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d SAN BORTOLO HOSPITAL   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute kidney injury; biomarkers; mortality; outcome; renal failure; treatment

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; KIDNEY INJURY MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYL BETA GLUCOSAMINIDASE; NESIRITIDE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE DISEASE; ACUTE HEART FAILURE; CARDIORENAL SYNDROME; CELL INFILTRATION; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; HEALTH CARE COST; HEART FUNCTION; HEMODYNAMICS; HUMAN; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; NARRATIVE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CARDIO-RENAL SYNDROME; HEART FAILURE; HEMODYNAMICS; HUMANS; INFLAMMATION; KIDNEY FUNCTION TESTS; PROGNOSIS; RISK FACTORS;

EID: 84906791158     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000404     Document Type: Review

References (63)

1. Haase M, Müller C, Damman K, et al: Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: Workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182:99-116
2. Zannad F, Mebazaa A, Juillière Y, et al; EFICA Investigators: Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006; 8:697-705
3. Ronco C, Haapio M, House AA, et al: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52:1527-1539
4. Hillege HL, Girbes AR, de Kam PJ, et al: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102:203-210
5. Winton FR: The influence of venous pressure on the isolated mammalian kidney. J Physiol 1931; 72:49-61
6. Liang KV, Williams AW, Greene EL, et al: Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008; 36:S75-S88
7. Chvojka J, Sykora R, Krouzecky A, et al: Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitisinduced septic shock in pigs. Crit Care 2008; 12:R164
8. Mullens W, Abrahams Z, Francis GS, et al: Prompt reduction in intraabdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 2008; 14:508-514
9. Verbrugge FH, Dupont M, Steels P, et al: Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol 2013; 62:485-495
10. Legrand M, Payen D: Understanding urine output in critically ill patients. Ann Intensive Care 2011; 1:13.
11. Rabb H: The promise of immune cell therapy for acute kidney injury. J Clin Invest 2012; 122:3852-3854
12. Fildes JE, Shaw SM, Yonan N, et al: The immune system and chronic heart failure: Is the heart in control? J Am Coll Cardiol 2009; 53:1013-1020
13. Grams ME, Rabb H: The distant organ effects of acute kidney injury. Kidney Int 2012; 81:942-948
14. F Gnanaraj J, von Haehling S, Anker SD, et al: The relevance of congestion in the cardio-renal syndrome. Kidney Int 2013; 83:384-391
15. Logeart D, Tabet JY, Hittinger L, et al: Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol 2008; 127:228-232
16. Testani JM, Chen J, McCauley BD, et al: Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122:265-272
17. Testani JM, Brisco MA, Chen J, et al: Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: Importance of sustained decongestion. J Am Coll Cardiol 2013; 62:516-524
18. van der Meer P, Postmus D, Ponikowski P, et al: The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 2013; 61:1973-1981
19. Felker GM, Lee KL, Bull DA, et al; NHLBI Heart Failure Clinical Research Network: Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364:797-805
20. Testani JM, Kimmel SE, Dries DL, et al: Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail 2011; 4:685-691
21. Bart BA, Goldsmith SR, Lee KL, et al; Heart Failure Clinical Research Network: Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 367:2296-2304
22. Testani JM, McCauley BD, Chen J, et al: Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail 2011; 17:993-1000
23. van Kimmenade RR, Januzzi JL Jr: Emerging biomarkers in heart failure. Clin Chem 2012; 58:127-138
24. Szymanski MK, Damman K, van Veldhuisen DJ, et al: Prognostic value of renin and prorenin in heart failure patients with decreased kidney function. Am Heart J 2011; 162:487-493
25. Parikh CR, Devarajan P: New biomarkers of acute kidney injury. Crit Care Med 2008; 36:S159-S165
26. Brisco MA, Coca SG, Chen J, et al: Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail 2013; 6:233-239
27. Manzano-Fernández S, López-Cuenca A, Januzzi JL, et al: Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes. Am J Cardiol 2012; 110:1240-1248
28. Lassus JP, Nieminen MS, Peuhkurinen K, et al; FINN-AKVA Study Group: Markers of renal function and acute kidney injury in acute heart failure: Definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 2010; 31:2791-2798
29. Silva D, Cortez-Dias N, Jorge C, et al: Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction. Am J Cardiol 2012; 109:1431-1438
30. Orenes-Piñero E, Manzano-Fernández S, López-Cuenca Á, et al: β-Trace protein: From GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol 2013; 8:873-881
31. Yndestad A, Landrø L, Ueland T, et al: Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 2009; 30:1229-1236
32. Maisel AS, Mueller C, Fitzgerald R, et al: Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely Decompensated Heart Failure (GALLANT) trial. Eur J Heart Fail 2011; 13:846-851
33. Dupont M, Shrestha K, Singh D, et al: Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 2012; 14:597-604
34. Lekawanvijit S, Kompa AR, Zhang Y, et al: Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: Implications for cardiorenal syndrome. Am J Physiol Heart Circ Physiol 2012; 302:H1884-H1893
35. Damman K, Ng Kam Chuen MJ, MacFadyen RJ, et al: Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 2011; 57:2233-2241
36. Legrand M, Dupuis C, Simon C, et al: Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: A retrospective observational study. Crit Care 2013; 17:R278
37. Drazner MH, Velez-Martinez M, Ayers CR, et al: Relationship of rightto left-sided ventricular filling pressures in advanced heart failure: Insights from the ESCAPE trial. Circ Heart Fail 2013; 6:264-270
38. Tanaka M, Yoshida H, Furuhashi M, et al: Deterioration of renal function by chronic heart failure is associated with congestion and oxidative stress in the tubulointerstitium. Intern Med 2011; 50:2877-2887
39. Guglin M, Rivero A, Matar F, et al: Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol 2011; 34:113-116
40. Damman K, Voors AA, Hillege HL, et al; CIBIS-2 Investigators and Committees: Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 2010; 12:974-982
41. Testani JM, Khera AV, St John Sutton MG, et al: Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 2010; 105:511-516
42. Mullens W, Abrahams Z, Francis GS, et al: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53:589-596
43. Damman K, van Deursen VM, Navis G, et al: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009; 53:582-588
44. Damman K, Navis G, Smilde TD, et al: Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007; 9:872-878
45. Van Biesen W, Yegenaga I, Vanholder R, et al: Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: A prospective analysis. J Nephrol 2005; 18:54-60
46. Park M, Vittinghoff E, Liu KD, et al: Urine biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have different patterns in heart failure exacerbation. Biomark Insights 2013; 8:15-18
47. Verbrugge FH, Dupont M, Shao Z, et al: Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and allcause mortality following decongestive therapy in acute decompensated heart failure. J Card Fail 2013; 19:621-628
48. Koyama S, Sato Y, Tanada Y, et al: Early evolution and correlates of urine albumin excretion in patients presenting with acutely decompensated heart failure. Circ Heart Fail 2013; 6:227-232
49. Shrestha K, Shao Z, Singh D, et al: Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Am J Cardiol 2012; 110:1329-1335
50. Breidthardt T, Socrates T, Drexler B, et al: Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012; 16:R2
51. Macdonald S, Arendts G, Nagree Y, et al: Neutrophil gelatinase-associated lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: A prospective observational study. BMC Cardiovasc Disord 2012; 12:8
52. Alvelos M, Pimentel R, Pinho E, et al: Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol 2011; 6:476-481
53. Aghel A, Shrestha K, Mullens W, et al: Serum neutrophil gelatinaseassociated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 2010; 16:49-54
54. van Deursen VM, Damman K, Voors AA, et al: Prognostic value of plasma NGAL for mortality in heart failure patients. Circ Heart Fail 2014; 7:35-42
55. Damman K, van Veldhuisen DJ, Navis G, et al: Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 2008; 10:997-1000
56. Niizeki T, Takeishi Y, Sasaki T, et al: Usefulness of albuminuria as a prognostic indicator in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2013; 111:1180-1186
57. Nymo SH, Ueland T, Askevold ET, et al: The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: Results from CORONA. J Intern Med 2012; 271:436-443
58. Jungbauer CG, Birner C, Jung B, et al: Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: Possible biomarkers of cardiorenal syndrome. Eur J Heart Fail 2011; 13:1104-1110
59. Damman K, Masson S, Hillege HL, et al: Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 2011; 32:2705-2712
60. deFilippi CR, Seliger SL, Maynard S, et al: Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 2007; 53:1511-1519
61. Ronco C: Kidney attack: Overdiagnosis of acute kidney injury or comprehensive definition of acute kidney syndromes? Blood Purif 2013; 36:65-68
62. Ronco C, McCullough PA, Chawla LS: Kidney attack versus heart attack: Evolution of classification and diagnostic criteria. Lancet 2013; 382:939-940
63. Reed SD, Kaul P, Li Y, et al: Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: Findings from ASCEND-HF. J Card Fail 2013; 19:611-620